BOSTON, MA and SAN FRANCISCO, CA, March 25th, 2026 - Spectrum Equity is proud to congratulate Managing Directors Jeff Haywood and Steve LeSieur on their placement on GrowthCap’s Top Healthcare Investors of 2026 list. Steve and Jeff have co-led the firm’s healthcare investment practice since 2015, focusing on high-growth software and data services companies across the healthcare continuum. This marks the fifth year both have earned a spot on the list.

In announcing the honorees, GrowthCap said: “This year’s awardees stand out as exceptional partners to their portfolio companies, limited partner investors, and firm colleagues, among others. They demonstrate a distinct ability to identify solid investment opportunities and apply their expertise, insight, and commitment to drive successful outcomes.”

Jeff currently serves on the boards of Definitive Healthcare (NASDAQ: DH), RxVantage, and VBA. He led Spectrum’s investment in PWNHealth and its subsequent sale to Everlywell. Past investments include GoodRx (NASDAQ: GDRX), Payer Compass (acquired by Zelis Healthcare), Datassential (acquired by New Mountain), Net Health (acquired by The Carlyle Group), Verisys (acquired by Aperture Health), Membersy (now Kleers-Membersy), Passport Health Communications (acquired by Experian), and MedHOK (acquired by Hearst Health).

“The founders we back are taking on some of the hardest, most entrenched problems in healthcare. We’re fortunate to act as partners in this important work.” — Jeff Haywood

Steve recently served on the board of GoodRx (NASDAQ: GDRX). Past investments include Payer Compass (acquired by Zelis Healthcare), Definitive Healthcare (NASDAQ: DH), MedHOK (acquired by Hearst Health), HealthMEDX (acquired by NetSmart), Passport Health Communications (acquired by Experian), and QTC Management (acquired by Lockheed Martin).

“Healthcare has real stakes—the companies we invest in are changing what care looks like for both patients and the people who deliver it. I’m grateful to support their innovation.” — Steve LeSieur

See the full list of investors on GrowthCap’s website here: The Top Healthcare Investors of 2026

The GrowthCap Top Healthcare Investors award is issued by GrowthCap, an independent 3rd-party that is not affiliated with Spectrum Equity. Spectrum Equity paid a fee to GrowthCap in connection with the promotion and distribution of this announcement following the award designation. The award was announced March 25th, 2026, and the time period for which the award was based Jan. 1st 2025-Feb. 27th, 2026. Spectrum Equity submitted the nomination for consideration on Feb. 27th, 2026, along with requested information about the firm. This award reflects GrowthCap’s determination based on its own criteria. For more information about GrowthCap and its award methodology, please visit www.growthcapadvisory.com. The award is not indicative of Spectrum Equity’s future performance and is not an endorsement by any client or investor.